Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

A Model for Predicting Response to PD-1 Inhibitors in NSCLC

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer

S. Hu-Lieskovan, A. Lisberg, J. Zaretsky, et al. (2019). Clinical Cancer Research. Cited 62 times. https://doi.org/10.1158/1078-0432.CCR-18-4275